BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22008731)

  • 1. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jan; 208(1):12-5. PubMed ID: 22008731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'.
    Wood MR; Lalancette RA; Bernal I
    Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):32-8. PubMed ID: 25567572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of "bath salts" purchased from California stores and the internet.
    Schneir A; Ly BT; Casagrande K; Darracq M; Offerman SR; Thornton S; Smollin C; Vohra R; Rangun C; Tomaszewski C; Gerona RR
    Clin Toxicol (Phila); 2014 Aug; 52(7):651-8. PubMed ID: 25089721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illicit bath salts: not for bathing.
    Kyle PB; Iverson RB; Gajagowni RG; Spencer L
    J Miss State Med Assoc; 2011 Dec; 52(12):375-7. PubMed ID: 22329114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
    Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
    Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones.
    Wojcieszak J; Andrzejczak D; Woldan-Tambor A; Zawilska JB
    Neurotox Res; 2016 Aug; 30(2):239-50. PubMed ID: 27295059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.
    De Felice LJ; Glennon RA; Negus SS
    Life Sci; 2014 Feb; 97(1):20-6. PubMed ID: 24231923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral pharmacology of designer cathinones: a review of the preclinical literature.
    Gregg RA; Rawls SM
    Life Sci; 2014 Feb; 97(1):27-30. PubMed ID: 24231450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3,4-methylene-dioxy-pyrovalerone (MDPV) epidemic?].
    Kalapos MP
    Orv Hetil; 2011 Dec; 152(50):2010-9. PubMed ID: 22112374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bath salts and synthetic cathinones: an emerging designer drug phenomenon.
    German CL; Fleckenstein AE; Hanson GR
    Life Sci; 2014 Feb; 97(1):2-8. PubMed ID: 23911668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current "legal highs".
    Johnson LA; Johnson RL; Portier RB
    J Emerg Med; 2013 Jun; 44(6):1108-15. PubMed ID: 23528960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic cathinones (bath salts): legal status and patterns of abuse.
    Fass JA; Fass AD; Garcia AS
    Ann Pharmacother; 2012 Mar; 46(3):436-41. PubMed ID: 22388331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral resolution and absolute configuration of the enantiomers of the psychoactive "designer drug" 3,4-methylenedioxypyrovalerone.
    Suzuki M; Deschamps JR; Jacobson AE; Rice KC
    Chirality; 2015 Apr; 27(4):287-93. PubMed ID: 25727807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.
    Thornton SL; Gerona RR; Tomaszewski CA
    J Med Toxicol; 2012 Sep; 8(3):310-3. PubMed ID: 22528592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone.
    Ross EA; Reisfield GM; Watson MC; Chronister CW; Goldberger BA
    Am J Med; 2012 Sep; 125(9):854-8. PubMed ID: 22682791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased abuse of the Internet drug MDPV in Västmanland. Severe cases of poisoning have given health care major problems].
    Lindeman E; Hultén P; Ström S; Enlund M; Al-Saffar Y; Helander A
    Lakartidningen; 2012 Oct 24-Nov 6; 109(43-44):1954-7. PubMed ID: 23198339
    [No Abstract]   [Full Text] [Related]  

  • 19. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications.
    White CM
    J Clin Pharmacol; 2016 Nov; 56(11):1319-1325. PubMed ID: 27029951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).
    Glennon RA; Young R
    Brain Res Bull; 2016 Sep; 126(Pt 1):111-126. PubMed ID: 27142261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.